Physician profile
Ali M Saifi
NPI 1376530303
$17,995.03
in general payments reported to CMS, 2019-2025
57 companies · $1,933 in 2025
The $1,933 reported for 2025 was more than what 93% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,248 · 2020: $1,833 · 2021: $4,021 · 2022: $2,365 · 2023: $2,638 · 2024: $2,958 · 2025: $1,933.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,405 · Education: $123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,405.35 |
| Education | $123.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,162.05 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $2,037.92 | 2020-2025 | Qulipta, Ubrelvy, Vraylar |
| Lilly USA, LLC | $1,540.28 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Biohaven Pharmaceuticals, INC. | $1,414.11 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $1,270.21 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Pfizer INC. | $1,037.14 | 2019-2025 | |
| Amgen INC. | $953.42 | 2019-2025 | Evenity, Repatha, Prolia |
| Janssen Pharmaceuticals, INC | $690.25 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $623.07 | 2019-2025 | Jardiance |
| Glaxosmithkline, LLC. | $519.27 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $495.65 | 2021-2025 | |
| Astellas Pharma US INC | $490.91 | 2019-2025 | Veozah, Myrbetriq |
| Abbott Laboratories | $488.25 | 2019-2025 | Freestyle Libre 2 |
| Novartis Pharmaceuticals Corporation | $444.91 | 2019-2025 | |
| Antares Pharma, INC. | $424.80 | 2019-2025 | Xyosted, Tlando, Nocdurna |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $421.35 | 2019-2023 | |
| Allergan, INC. | $351.13 | 2019-2021 | |
| Amarin Pharma, INC. | $245.80 | 2019-2022 | |
| Dexcom, INC. | $203.54 | 2021-2025 | Dexcom G6 Transmitter |
| Corcept Therapeutics | $166.35 | 2024-2025 | Korlym |
| Sumitomo Pharma America, INC. | $143.27 | 2023-2025 | Gemtesa |
| Teva Pharmaceuticals USA, INC. | $132.71 | 2019-2021 | |
| Exact Sciences Corporation | $131.70 | 2023-2025 | Cologuard Collection Kit |
| Esperion Therapeutics, INC. | $116.22 | 2021-2024 | Nexletol |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $113.93 | 2019-2024 | Xifaxan |
| Axsome Therapeutics, INC. | $103.59 | 2025 | Sunosi, Auvelity |
| Sunovion Pharmaceuticals INC. | $93.13 | 2019-2022 | |
| Scilex Pharmaceuticals INC. | $91.29 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $85.46 | 2019-2021 | |
| Myriad Women'S Health, INC. | $82.34 | 2023 | Myrisk |
| Jazz Pharmaceuticals INC. | $72.69 | 2019-2021 | |
| Idorsia Pharmaceuticals US INC | $67.46 | 2022-2023 | Quviviq |
| Renalytix Ai, INC. | $64.52 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Merck Sharp & Dohme LLC | $64.03 | 2019-2020 | |
| Nevro Corp. | $54.36 | 2024 | Senza |
| Halozyme INC | $51.88 | 2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $50.13 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $49.79 | 2019-2025 | Zoryve, Seglentis, Livalo |
| Boston Scientific Corporation | $47.41 | 2023-2025 | General - Pain Management, Watchman Access System |
| Horizon Therapeutics Plc | $44.91 | 2019-2023 | Krystexxa |
| Opko Pharmaceuticals, LLC | $40.50 | 2023 | Rayaldee |
| Radius Health, INC. | $39.17 | 2023 | Tymlos |
| Eisai INC. | $31.86 | 2021 | |
| Insmed, INC. | $29.96 | 2025 | Arikayce |
| Gilead Sciences, INC. | $26.57 | 2021 | |
| Nestle Healthcare Nutrition INC. | $18.91 | 2021 | |
| Kci USA, INC. | $18.37 | 2019 | |
| Phathom Pharmaceuticals, INC. | $18.21 | 2025 | Voquezna |
| Medtronic Vascular, INC. | $17.76 | 2020 | |
| Tms Neurohealth Centers INC. | $16.03 | 2025 | Tms Neurohealth Centers INC. |
| Almatica Pharma LLC | $15.97 | 2021 | |
| Phadia US INC. | $15.71 | 2022 | |
| Acerus Pharmaceuticals Corporation | $14.73 | 2021 | |
| Bioventus LLC | $14.42 | 2023 | Durolane |
| Takeda Pharmaceuticals U.S.A., INC. | $13.78 | 2019 | |
| Vistapharm, INC. | $11.62 | 2021 | |
| Kvk-Tech, INC. | $10.23 | 2019-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Saifi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.